Top of this page
Skip navigation, go straight to the content Newsroom UCB U.S. News


  • UCB’s U.S. Neurology Team Wins EyeForPharma Award for Agile Transformation


    (L to R): Members of the U.S. Neurology Internal Engine Stephanie Hunter-Banks, Jim Hlavenka, Brad Chapman, Trenton Merideth, Tonja Pitts

    UCB’s U.S. Neurology team won a 2019 EyeForPharma award last night in the “Most Promising Agile Transformation” category, which recognizes an experimental initiative that has the potential to disrupt the status quo. The award was presented for the team’s Internal Engine transformation, fulfilling the award criteria of showing agility through rapid creation of a service that touched real customers before being refined and assessed through smart measurement.

    Read more

  • Patient-Driven Approach to Innovation

    At UCB, our approach to innovation is designed around the patient and their individual experience. Every day, Chris Protos, Solution Enablement Lead, wakes up and thinks about ways we can continue to keep patients at the heart of everything we do. Hear more from Chris about how we’re addressing gaps in patient care through our patient-driven approach to innovation by watching the video below.

    Read more

  • What You See Is What You Get

    DenelleWaynick Quote Headshot BlogPost
    UCB's Denelle Waynick, VP, Legal Affairs (U.S.), U.S. General Counsel and Global Head, Enterprise Risk Management, leads by example by being true to herself to encourage others to do so too. Read more from Denelle on why by being authentic to yourself, you become stronger as an individual, leader, and employee. Read the full article on LinkedIn.

    Read more

  • UCB PharmD Fellows Have a Big Impact on Patients

    Posted by Katelyn Snider, U.S. Communications & Public Affairs
    UCB Global Regulatory Affairs Fellows (L to R): Howraa Alasker, PharmD and Tanya Chaudhri, PharmD, RPh

    The 2020-2022 UCB Global Regulatory Affairs (GRA) PharmD Fellowship Program, a collaboration with the Industry Pharmacists Organization (IPhO), is a 2-year rotational program located at UCB’s Atlanta campus aimed at growing top regulatory talent for the future. Established in 2017, the Fellowship Program is designed to provide PharmD graduates with the opportunity to learn and experience all aspects of regulatory affairs under the mentorship of experienced preceptors. Applications are being accepted now until November 1, 2019. Learn more about the fellowship from current fellow, Tanya Chaudhri, PharmD, RPh.

    Read more

  • UCB and University of Washington Collaborate on Engaging Community Pharmacists to Improve Care for People Living with Epilepsy

    Posted by Allyson Funk, Head of U.S. Communications and Public Affairs
    UCB is collaborating with the University of Washington to improve care delivery for people living with epilepsy by engaging community pharmacists.

    Read more

  • Announcing the 2019 UCB Family Epilepsy Scholarship Winners and the Addition of 6 New Scholarships

    Posted by Allyson Funk, Head of U.S. Communications and Public Affairs
    UCB is pleased to announce 38 recipients were awarded the 2019 UCB Family Epilepsy Scholarship. This year’s UCB Family Epilepsy Scholarship program includes six additional awards. We awarded a $10,000 Joe D’Souza Memorial Scholarship along with five additional $5,000 scholarships for 2019.

    Read more

  • UCB and DEARhealth Collaborate on New Software to Improve Patient Care

    UCB is collaborating with DEARhealth, Inc. to improve care delivery for people living with epilepsy. More than 1 in 26 Americans will experience epilepsy at some point in their lives, and many also suffer from stigma around their condition.

    Read more

  • Beyond What’s Required: Thoughtful Clinical Results

    UCB is in San Diego for DIA-Global 2019 this week. Ahead of her presentation, Liz Roberts, our Global Public Policy Lead, shares insights from the industry perspective on clinical trial disclosure and data transparency, and what UCB is doing to keep patients at the center of our work in this space. For more, see Liz speak today, June 25, 2019 at 2:00 p.m. in room 4 (session #260).

    Read more

  • UCB’s Global Clinical Development in Raleigh

    Posted by Becky Malone, Engagement and Communications
    From discovery to development to delivery, how we do business has been transformed and redesigned around the patient’s individual experience. At UCB, patients are at the heart of everything we do, inspiring us and driving the ways in which we research, develop, and study differentiated treatments for patients. For 18 years, UCB BioSciences has been in the Research Triangle Park (RTP) in North Carolina and is an integral part of UCB’s mission to bring differentiated medicines to patients.

    Read more

  • UCB Boston Research is Advancing Medical Innovation

    Posted by Katelyn Snider, U.S. Communications and Public Affairs
    UCB_Boston Promo_blog_1280x960_v2_1
    Every day, UCB researchers come to work driven by a singular purpose – to create value for people living with severe disease. That’s because, across the world, patients depend on the important work of scientific research to find new medical innovations that will help them achieve their goals. From the “breakthrough” moments in discovery, development, and delivery, we are dedicated to finding solutions for the unmet needs of patients.

    Read more